25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Market cap: $99.8M (12/21/2025)
Price: $2.19
Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
To Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology
Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
News
Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement